BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
242 results:

  • 1. CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
    Shen J; Ma Z; Yang J; Qu T; Xia Y; Xu Y; Zhou M; Liu W
    BMC Cancer; 2024 Apr; 24(1):511. PubMed ID: 38654205
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Moracin D suppresses cell growth and induces apoptosis via targeting the XIAP/PARP1 axis in pancreatic cancer.
    Zhong X; Ke X; Yang H; Ye X; Li C; Pan J; Ran W; Wang F; Cui H
    Phytomedicine; 2024 Jun; 128():155527. PubMed ID: 38489888
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A study on the role of Taxifolin in inducing apoptosis of pancreatic cancer cells: screening results using weighted gene co-expression network analysis.
    Chen SJ; Ren LK; Fei XB; Liu P; Wang X; Zhu CH; Pan YZ
    Aging (Albany NY); 2024 Feb; 16(3):2617-2637. PubMed ID: 38305809
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
    Bai X; Xu Y; Liu Y
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma.
    Li XQ; Yin SQ; Chen L; Tulamaiti A; Xiao SY; Zhang XL; Shi L; Miao XC; Yang Y; Xing X
    BMC Cancer; 2024 Jan; 24(1):116. PubMed ID: 38262966
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the JAK2/STAT3 pathway.
    Luo X; Ye Z; Xu C; Chen H; Dai S; Chen W; Bao G
    Mol Biol Rep; 2024 Jan; 51(1):176. PubMed ID: 38252208
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Insulin-like growth factor 2 mRNA-binding protein 2 is a therapeutic target in ovarian cancer.
    Yuan J; Li X; Wang F; Liu H; Guan W; Xu G
    Exp Biol Med (Maywood); 2023 Dec; 248(23):2198-2209. PubMed ID: 38084732
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgically treated pancreatic ductal adenocarcinoma.
    Detlefsen S; Boldt HB; Burton M; Thomsen MM; Rasmussen LG; Ørbeck SV; Pfeiffer P; Mortensen MB; de Stricker K
    Hum Pathol; 2023 Dec; 142():68-80. PubMed ID: 37977512
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lysine demethylase 3A in hypoxic macrophages promotes ovarian cancer development through regulation of the vascular endothelial growth factor A/Akt signaling.
    Song Y; Li L; Xi Y
    Tissue Cell; 2023 Dec; 85():102253. PubMed ID: 37890327
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Biological function of C-X-C Motif Chemokine Ligand 1 gene (CXCL1) in ovarian malignant tumors.
    Li Z; Huang N; Zhang W; Li L
    Hum Exp Toxicol; 2023; 42():9603271231203392. PubMed ID: 37787042
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Integrative analysis of cuproptosis-associated genes for predicting immunotherapy response in single-cell and multi-cohort studies.
    Li H; Wang Y; Li G; Xiong J; Qin L; Wen Q; Yue C
    J Gene Med; 2024 Jan; 26(1):e3600. PubMed ID: 37776237
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Copine 1 predicts poor clinical outcomes by promoting M2 macrophage activation in ovarian cancer.
    Sheng B; Zhao B; Dong Y; Zhang J; Wu S; Ji H; Zhu X
    Carcinogenesis; 2023 Dec; 44(10-11):748-759. PubMed ID: 37747823
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CMTM6 as a potential therapy target is associated with immunological tumor microenvironment and can promote migration and invasion in pancreatic adenocarcinoma.
    Gao H; Yin J; Guan X; Zhang S; Peng S; Liu X; Xing F
    Funct Integr Genomics; 2023 Sep; 23(4):306. PubMed ID: 37726578
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis.
    Dong QT; Ma DD; Gong Q; Lin ZY; Li ZH; Ye JX; Qin CH; Jin WD; Zhang JX; Zhang ZY
    Sci Rep; 2023 Sep; 13(1):15144. PubMed ID: 37704682
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. REG3A promotes proliferation and DDP resistance of ovarian cancer cells by activating the PI3K/Akt signaling pathway.
    Jiang L; Liu Y; Liu M; Zheng Y; Chen L; Shan F; Ji J; Cao Y; Kai H; Kang X
    Environ Toxicol; 2024 Jan; 39(1):85-96. PubMed ID: 37665173
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian cancer (HGSOC) Based on The cancer Genome Atlas Analysis.
    Iżycka N; Zaborowski MP; Ciecierski Ł; Jaz K; Szubert S; Miedziarek C; Rezler M; Piątek-Bajan K; Synakiewicz A; Jankowska A; Figlerowicz M; Sterzyńska K; Nowak-Markwitz E
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628927
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PABPC1 promotes cell proliferation and metastasis in pancreatic adenocarcinoma by regulating COL12A1 expression.
    Yao W; Yao Y; He W; Zhao C; Liu D; Wang G; Wang Z
    Immun Inflamm Dis; 2023 Jul; 11(7):e919. PubMed ID: 37506150
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Aberrantly Expressed lncRNA LINC00847 May Serve as a Promising Prognostic Factor for Thyroid cancer.
    Hei G; Yu Y; Wu Y; Huang J
    Horm Metab Res; 2023 Nov; 55(11):794-800. PubMed ID: 37493640
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. GABRP Promotes the Metastasis of Pancreatic cancer by Activation of the MEK/ERK Signaling Pathway.
    Meng Y; Li R; Geng S; Chen W; Jiang W; Li Z; Hao J; Xu Z
    Biochem Genet; 2024 Feb; 62(1):242-253. PubMed ID: 37326897
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. LHPP Inhibits the Viability, Migration, and Proliferation of PDAC Cells and Significantly Affects the Expression of SDC1 and S100p.
    Xia Z; Zhao S; Gao X; Sun H; Yang F; Zhu H; Gao H; Lu J; Zhou X
    Technol Cancer Res Treat; 2023; 22():15330338231177807. PubMed ID: 37321804
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 13.